MedTrace Logo

Computational Cranial and Cervical Muscle Network in Normal and Disordered Voice

NCT04713033 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2025-05-01

No results posted yet for this study

Summary

The long-term goal is to transform the diagnosis and treatment of dysphonia by elucidating cervical and cranial neuromuscular mechanisms underlying typical and disordered voicing. The overall objective of this application is to propose and evaluate a novel objective spectrotemporal diagnostic tool measuring functional cervical-cranial muscle network activity in typical and disordered speakers.The purpose of this study is to improve our understanding of how the vocal tract and the muscles of the larynx and the head work at baseline and after vocal fatigue.

Conditions

  • Dysphonia

Interventions

DIAGNOSTIC_TEST

surface electromyogram (sEMG)

A device that measures electrical signals from your skin will be connected to those stickers and will make a graph that is characteristic to your vocal function.

DIAGNOSTIC_TEST

flexible laryngoscopy

A device that examines the throat and nasal passages. The flexible laryngoscope or "scope" consists of an eyepiece and a fiber-optic light enclosed in a thin, flexible tube. The scope looks like a strand of black spaghetti with a tiny light on the end of it. The scope is inserted through the nose, and can be moved around to help the doctor see all areas of the nasal passages and throat.

Sponsors & Collaborators

  • National Institute on Deafness and Other Communication Disorders (NIDCD)

    collaborator NIH

  • NYU Langone Health

    lead OTHER

Principal Investigators

  • Aaron Johnson · NYU Langone Health

Eligibility

Min Age
18 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-09
Primary Completion
2022-05-25
Completion
2022-05-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04713033 on ClinicalTrials.gov